HIF1A and hepatocellular carcinoma: However, neither a PKM2 nuclear translocation antagonizer (TEPP) nor a HIF-1α inhibitor (α-ketoglutarate) could affect the expression of PD-L1 in SAA-stimulated neutrophils derived from the blood of HCC patients (Supplementary Fig. 12b, c).